Multifunctional nanoparticles - properties and prospects for their use in human medicine

Trends in Biotechnology

Volumn 26, Issue 8, 2008, Pages 425-433

  Sanvicens, Nuria ^a   Marco, M Pilar ^a  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; GENE TRANSFER; HEALTH; NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY; PHOTOACOUSTIC EFFECT;

(PL) PROPERTIES; CLINICAL CONDITIONS; EFFICIENT TREATMENT; ELSEVIER (CO); GENE DELIVERY; HEALTH EFFECTS; HUMAN MEDICINE; MULTI-FUNCTIONAL NANOPARTICLES; NANO SCALING; NOVEL MATERIALS; SECONDARY EFFECTS;

NANOSTRUCTURED MATERIALS;

NANOPARTICLE;

DEVICE; MEDICAL TECHNOLOGY; NANOANALYSIS; NANOTECHNOLOGY; NANOTOXICOLOGY; NEOPLASM; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW;

DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; NANOMEDICINE; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 47049099053     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2008.04.005     Document Type: Review

References (82)

1. Zhang L., et al. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83 (2008) 761-769
2. Yezhelyev M.V., et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 7 (2006) 657-667
3. Pison U., et al. Nanomedicine for respiratory diseases. Eur. J. Pharmacol. 533 (2006) 341-350
4. Wagner V., et al. The emerging nanomedicine landscape. Nat. Biotechnol. 24 (2006) 1211-1217
5. Willner I., et al. Nanoparticle-enzyme hybrid systems for nanobiotechnology. FEBS J. 274 (2007) 302-309
6. Penn S.G., et al. Nanoparticles for bioanalysis. Curr. Opin. Chem. Biol. 7 (2003) 609-615
7. Katz E., and Willner I. Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications. Angew. Chem. Int. Ed. Engl. 43 (2004) 6042-6108
8. Torchilin V.P. Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 58 (2006) 1532-1555
9. Salem A.K., et al. Multifunctional nanorods for gene delivery. Nat. Mater. 2 (2003) 668-671
10. Park H., et al. Multifunctional nanoparticles for photothermally controlled drug delivery and magnetic resonance imaging enhancement. Small 4 (2008) 192-196
11. Yu K.N., et al. Multiplex targeting, tracking, and imaging of apoptosis by fluorescent surface enhanced Raman spectroscopic dots. Bioconjug. Chem. 18 (2007) 1155-1162
12. Sawant R.M., et al. 'SMART' drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug. Chem. 17 (2006) 943-949
13. Medarova Z., et al. In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 13 (2007) 372-377
14. Derfus A.M., et al. Targeted quantum dot conjugates for siRNA delivery. Bioconjug. Chem. 18 (2007) 1391-1396
15. Gao J., et al. Fluorescent magnetic nanocrystals by sequential addition of reagents in a one-pot reaction: a simple preparation for multifunctional nanostructures. J. Am. Chem. Soc. 129 (2007) 11928-11935
16. Yang J., et al. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew. Chem. Int. Ed. Engl. 46 (2007) 8836-8839
17. Farokhzad O.C., et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6315-6320
18. Tosi G., et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. J. Control. Release 122 (2007) 1-9
19. Vail D.M., et al. Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. Semin. Oncol. 31 (2004) 16-35
20. Zhang Y., et al. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer. Mol. Vis. 9 (2003) 465-472
21. Wood K.C., et al. Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide. Bioconjug. Chem. 19 (2008) 403-405
22. Gref R., et al. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
23. Owens III D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307 (2006) 93-102
24. Breunig M., et al. Polymers and nanoparticles: intelligent tools for intracellular targeting?. Eur. J. Pharm. Biopharm. 68 (2008) 112-128
25. Tada H., et al. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res. 67 (2007) 1138-1144
26. Choi H.S., et al. Renal clearance of quantum dots. Nat. Biotechnol. 25 (2007) 1165-1170
27. Zhang Y., et al. In vitro and in vivo toxicity of CdTe nanoparticles. J. Nanosci. Nanotechnol. 7 (2007) 497-503
28. Kirchner C., et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 5 (2005) 331-338
29. Lovrić J., et al. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 83 (2005) 377-386
30. Pisanic II T.R., et al. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28 (2007) 2572-2581
31. Sayes C.M., et al. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 26 (2005) 7587-7595
32. Pernodet N., et al. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2 (2006) 766-773
33. Jia G., et al. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ. Sci. Technol. 39 (2005) 1378-1383
34. Nel A., et al. Toxic potential of materials at the nanolevel. Science 311 (2006) 622-667
35. Hoshino A., et al. Use of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicity. J. Artif. Organs 10 (2007) 149-157
36. Connor E.E., et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1 (2005) 325-327
37. Chan W.H., et al. CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals. Toxicol. Lett. 167 (2006) 191-200
38. Lovric J., et al. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem. Biol. 12 (2005) 1227-1234
39. Voura E.B., et al. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med. 10 (2004) 993-998
40. McAteer M.A., et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat. Med. 13 (2007) 1253-1258
41. Akerman M.E., et al. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12617-12621
42. Oberdörster G., et al. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113 (2005) 823-839
43. Fischer H.C., and Chan W.C. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 18 (2007) 565-571
44. Dailey L.A., et al. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol. Appl. Pharmacol. 215 (2006) 100-108
45. Ballou B., et al. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15 (2004) 79-86
46. Gopee N.V., et al. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol. Sci. 98 (2007) 249-257
47. Rupp R., et al. VivaGel (SPL7013 Gel): a candidate dendrimer-microbicide for the prevention of HIV and HSV infection. Int. J. Nanomedicine 2 (2007) 561-566
48. Kajita M., et al. Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic. Res. 41 (2007) 615-626
49. Singh N., et al. Treatment of neurodegenerative disorders with radical nanomedicine. Ann. N.Y. Acad. Sci. 1122 (2007) 219-230
50. Sathe T.R., et al. Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation. Anal. Chem. 78 (2006) 5627-5632
51. Dubertret B., et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298 (2002) 1759-1762
52. Pinaud F., et al. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J. Am. Chem. Soc. 126 (2004) 6115-6123
53. Lukyanov A.N., et al. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J. Control. Release 100 (2004) 135-144
54. Zhu J., et al. Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. Bioconjug. Chem. 18 (2007) 1366-1369
55. Kukowska-Latallo J.F., et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65 (2005) 5317-5324
56. Bartlett D.W., et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15549-15554
57. Li W., and Szoka F.C.J. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24 (2007) 438-449
58. Luten J., et al. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Control. Release 126 (2007) 97-110
59. Skirtach A.G., et al. Laser-induced release of encapsulated materials inside living cells. Angew. Chem. Int. Ed. Engl. 45 (2006) 4612-4617
60. Stover T.C., et al. Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug. Biomaterials 29 (2008) 359-369
61. Hu S.H., et al. Magnetic-sensitive silica nanospheres for controlled drug release. Langmuir 24 (2008) 239-244
62. Trewyn B.G., et al. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem. Commun. (Camb.). 21 (2007) 3236-3245
63. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
64. Chen H.T., et al. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J. Am. Chem. Soc. 126 (2004) 10044-10048
65. Neerman M.F., et al. In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery. Int. J. Pharm. 281 (2004) 129-132
66. Huczko A., et al. Physiological testing of carbon nanotubes: are they asbestos-like?. Fullerene Sci. Techn. 9 (2001) 251-254
67. Warheit D.B., et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 77 (2004) 117-125
68. Cheng F.Y., et al. Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications. Biomaterials 26 (2005) 729-738
69. Qian X., et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26 (2008) 83-90
70. Su C.H., et al. Nanoshell magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 129 (2007) 2139-2146
71. Lee C.C., et al. Designing dendrimers for biological applications. Nat. Biotechnol. 23 (2005) 1517-1526
72. Polizu S., et al. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology. J. Nanosci. Nanotechnol. 6 (2006) 1883-1904
73. Medintz I.L., et al. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4 (2005) 435-446
74. Lu A.H., et al. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. Engl. 46 (2007) 1222-1244
75. Huang X., et al. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomed. 2 (2007) 681-693
76. Giepmans B.N., et al. Correlated light and electron microscopic imaging of multiple endogenous proteins using quantum dots. Nat. Methods 2 (2005) 743-749
77. Agrawal A., et al. Nanometer-scale mapping and single-molecule detection with color-coded nanoparticle probes. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3298-3303
78. El-Boubbou K., et al. Magnetic glyco-nanoparticles: a unique tool for rapid pathogen detection, decontamination, and strain differentiation. J. Am. Chem. Soc. 129 (2007) 13392-13393
79. Georganopoulou D.G., et al. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2273-2276
80. Cao Y.C., et al. Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science 297 (2002) 1536-1540
81. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
82. Emerich D.F., and Thanos C.G. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol. Eng. 23 (2006) 171-184